Sensitisation to recombinant Aspergillus fumigatus allergens and clinical outcomes in COPD
Background Variable clinical outcomes are reported with fungal sensitisation in chronic obstructive pulmonary disease (COPD), and it remains unclear which fungi and what allergens associate with the poorest outcomes. The use of recombinant as opposed to crude allergens for such assessment is unknown...
Saved in:
Main Authors: | Tiew, Pei Yee, Narayana, Jayanth Kumar, Li Quek, Marilynn Swee, Ang, Yan Ying, San Ko, Fanny Wai, Poh, Mau Ern, Jaggi, Tavleen Kaur, Xu, Huiying, Thng, Kai Xian, Koh, Mariko Siyue, Tee, Augustine, Hui, David Shu Cheong, Abisheganaden, John Arputhan, Tsaneva-Atanasova, Krasimira, Chew, Fook Tim, Chotirmall, Sanjay H. |
---|---|
Format: | Article |
Published: |
European Respiratory Society
2023
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/39123/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Environmental fungal sensitisation associates with poorer clinical outcomes in COPD
by: Tiew, Pei Yee, et al.
Published: (2020) -
High frequency of allergic bronchopulmonary aspergillosis in bronchiectasis-COPD overlap
by: Tiew, Pei Yee, et al.
Published: (2022) -
A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD
by: Tiew, Pei Yee, et al.
Published: (2021) -
Integrative microbiomics in bronchiectasis exacerbations
by: Mac Aogain, Micheal, et al.
Published: (2021) -
COPD? what is that?
by: Ismawi, Hidayatul Radziah
Published: (2015)